Raleigh, NC - February 04, 2026 - PRESSADVANTAGE - Porter Ophthalmology announced the release of a comprehensive new ...

Raleigh, NC - February 17, 2026 - PRESSADVANTAGE - Porter Ophthalmology continues to be recognized as a premier ...

Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...

Please provide your email address to receive an email when new articles are posted on . From cornea to retina and glaucoma, ophthalmology offers a number of subspecialties with their own pros and cons ...

Advanced technology lenses work best in pristine eyes. Problems with ocular alignment, pupil size, ocular surface disease, irregular astigmatism, corneal dystrophies, scarring, and diseases of the ...

Please provide your email address to receive an email when new articles are posted on . Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative ...

Ophthalmology is a specialization in medicine, but there are also several subspecialties of ophthalmology, which focus on certain diseases or parts of the eyes. This is not a complete list of all ...

Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced ...